Differences between treatments may be primarily attributed to metabolic regulators such as Pparg and Ppara as well as Atf1, and Atf2, which have been reported as being selectively under-expressed in RA synovial extracts even when compared to osteoarthritis (OA) controls [33]. This evidence concerns the gene ATF2 and osteoarthritis.